Navigation Links
Discontinuing Overused Pain Medications Helps Revert Migraines

In a study published in the journal "Headache," researchers at the Samsung Medical Center in Seoul have reported that discontinuing overused pain medication// , following an exercise regimen and taking preventive medications, may help revert transformed migraines to normal migraine.

Transformed migraine otherwise called chronic daily headache occurs when individuals begin to experience a daily pattern of migraine. Aggressive treatment early in the course of migraine is essential to prevent the occurrence of an uncontrolled daily pattern and greater sensitivity to pain.

The study was conducted on 136 patients diagnosed with transformed migraines for a year. Dr. Chin-Sang Chung and colleagues who conducted the study found that 70 percent of patients participating in the study were relieved of their chronic headaches after abruptly discontinuing overused pain medications and other drugs, while the remainder of patients failed to improve.

The study also found that using preventive drugs and regular exercise aided in treatment, while smoking cessation, avoiding caffeine, and avoiding alcohol didn’t seem to have an effect.


'"/>




Page: 1

Related medicine news :

1. What happens when Medications go wrong?
2. Medications to Prevent Relapse to Cocaine Use
3. More Elderly Take Inappropriate and Harmful Medications
4. Medications for depression
5. Medications linked to xerostomia and caries
6. Analyzing The Side Effects Of Some Common Medications
7. The Risks Involved In Purchase Of Over The Counter Medications
8. Trust In Doctors Can Affect Taking Medications
9. Medications Detected In Recycled Water In Los Angeles
10. Children Being Given "Adult" Medications, Report Says
11. Kidney Transplant Recipients Tardy In Taking Vital Medications
Post Your Comments:
(Date:1/22/2015)... 22, 2015 Yesterday, Senator Holly ... and Kristin Olsen (R-Modesto) were honored by the ... advancing biotechnology, biomedical science, medical device and pharmaceutical ... received the “2014 Life Sciences Champion” award from ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... component of overall health care gains momentum worldwide, Rev. ... York-based HealthCare Chaplaincy Network (HCCN), will be the ... advance spiritual care in Israel’s public health system. , The ...
(Date:1/22/2015)... Lower-Auto-Insurance.com has released a new blog post explaining the importance ... reducing the costs of an auto insurance policy . , ... lower prices for their vehicle insurance policies. The safety a vehicle ... costs. Because of this, drivers should always carry a first ...
(Date:12/26/2014)... 2014 The US represents the largest market ... 2013, GlobalData’s forecast estimates that sales of branded therapies were ... to the high incidence of the disease, high drug treatment ... and China. Increased sales of CRC therapies over the forecast ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... , WEDNESDAY, Nov. 3 (HealthDay News) -- Friendly ... challenges, but conversations that are competitive in tone aren,t helpful, ... talking to other people, the way you do when you,re ... a psychologist and researcher at the Institute for Social Research ...
... are less healthy than their English counterparts, but they live as ... new study by researchers from the RAND Corporation and the Institute ... aged 55 to 64 have higher rates of chronic diseases ... rate. And Americans age 65 and older -- while still sicker ...
... Mitchell, M.D., clinical professor, Department of Medical Oncology ... and associate director of Diversity Programs for the ... ,Physician of the Year, by CancerCare, a national ... to anyone affected by cancer: people with cancer, ...
... WEDNESDAY, Nov. 3 (HealthDay News) -- Higher levels of ... for Medicare patients, a new study has found. ... Information Set revealed wide variation across the United States ... inappropriate prescriptions for the elderly, said the researchers at ...
... Film director Ken Loach has officially opened a new ... between parents and children with hearing difficulties. The ... Health Research (NIHR) Biomedical Research Unit in Hearing, a ... Trust and the Medical Research Council Institute for Hearing ...
... the Cincinnati Veterans Affairs (VA) Medical Center have found that ... therapies for high blood pressure do not often adhere to ... online edition of the American Journal of Nephrology . ... Cincinnati VA, showed that treatment of hypertension in patients with ...
Cached Medicine News:Health News:Good Conversation Can Boost Brain Power, Study Finds 2Health News:Americans less healthy than English, but live as long or longer, study finds 2Health News:Americans less healthy than English, but live as long or longer, study finds 3Health News:CancerCare names Jefferson professor Physician of the Year 2Health News:Pricey Drugs May Not Mean Better Care 2Health News:Film director launches pioneering hearing research 2Health News:Medication adherence improves blood pressure control in chronic kidney disease 2
(Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... personalized immune therapies for operable and inoperable solid tumor cancers, ... at the 7 th Annual Phacilitate Immunotherapy Forum in ... presentation at Phacilitate will take place on January 26 at ...
(Date:1/23/2015)... , Jan. 23, 2015 More than a third ... quarter of those with private insurance, filled a prescription for ... a report in this week,s Morbidity and Mortality Weekly Report ... care providers to treat moderate to severe pain.  They are ...
(Date:1/23/2015)... YORK , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ... board of directors of Advaxis, Inc. ("Advaxis" or the ... board has breached its fiduciary duties to shareholders. ... on an investing website reporting that Advaxis had misrepresented ...
Breaking Medicine Technology:NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2
... 7, 2007 - REGENERX,BIOPHARMACEUTICALS' (AMEX: RGN), www.regenerx.com ... the 2007 Association for Research in,Vision and ... May 9th to discuss TB4's ability to ... process closely,associated with inflammation that, if not ...
... TSX-V: PGA, VANCOUVER, May 07, 2007 /PRNewswire-FirstCall/ - ... results from its Phase I/II study of PAC-113, ... and active,in the treatment of oral Candida infection ... of care. Based on these results,the Company plans ...
Cached Medicine Technology:Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting 2Dr. Gabriel Sosne to Present New TB4 Data at 2007 ARVO Meeting 3Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 2Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 3Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 4Pacgen Announces Positive Results from Phase I/II Trial of Novel,Antifungal Drug 5
... is a safe, non-surgical process that ... tighten skin and reverse the signs ... dermis to cause collagen contraction while ... In addition, Titan can stimulate long-term ...
... The smallest, lightest, smartest choice , ... or neurological, ... environment. But will the device ... on its signal quality? Will the battery last? Is it comfortable, ...
... The modular AU5400 is a high-volume analyzer ... productivity of the AU5200 analyzer and the ... automates and consolidates chemistry-immuno testing with up ... to 6,600 tests per hour. Choose from ...
... the quantitative determination of Erythropoietin (EPO) in human ... diagnostic use, as an aid in the diagnosis ... the administration of recombinant erythropoietin as a biologic ... erythropoietin assay may be used also to aid ...
Medicine Products: